UK-432097

Star0

DB12691InvestigationalSmall molecule

UK-432,097 has been used in trials studying the treatment of Pulmonary Disease, Chronic Obstructive.

Mechanism: Pharmacologically active on Adenosine receptor A2a
Curator reviewed
Formula / weight: C₄₀H₄₇N₁₁O₆ · 777.8713 g/mol (avg)
Code names: UK-432,097

Resolves to

Compound

UNII8L3OAJ1R5ACAS380221-63-6ChEMBLCHEMBL1096896PubChem9833519

Structure

InChIKeyZOTHAEBAWXWVID-HXEFRTELSA-NSMILESCCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=C(N=C2NCC(C1=CC=CC=C1)C1=CC=CC=C1)C(=O)NCCNC(=O)NC1CCN(CC1)C1=NC=CC=C1

Targets

P29274ADORA2A

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with UK-432097, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account